一只小鼠的敲门模型暴露了在G1和S阶段调节p27Kip1的序列蛋白质分解途径
N P Malek1, H Sundberg, S McGrew
1Howard Hughes Medical Institute, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104, USA.
Nature
|September 21, 2001
概括
蛋白质p27Kip1调节细胞分裂. 虽然通过T187的酸化阻断其降解对增殖的影响很小,但发现了第二个G1特异性降解途径.
科学领域:
- 分子生物学分子生物学
- 细胞循环规则 细胞循环规则
- 癌症生物学 癌症生物学
背景情况:
- 蛋白质p27Kip1是细胞分裂的关键抑制剂,控制细胞周期的退出和重新进入.
- 低p27水平与过度的细胞增殖有关,特别是在癌症中.
- 通过翻译和蛋白质循环发生p27调节,Cdk2通过T187酸化启动蛋白质分解.
研究的目的:
- 为了研究Cdk2介导的p27蛋白解路径的体内意义.
- 了解细胞周期期间控制p27蛋白水平的机制.
主要方法:
- 产生了一种具有突变p27基因 (p27T187A) 的小鼠模型,以阻止T187酸化.
- 在p27T187A细胞中体外和体外分析细胞增殖和p27蛋白水平.
- 研究替代的p27降解途径.
主要成果:
- 表达p27T187A的细胞在S和G2阶段显示p27下调受损.
- 这种损伤对细胞增殖产生了令人惊的适度的影响.
- 发现了一种新型的,由基因激活的蛋白质分解途径,该途径在G1期间专门降解p27.
结论:
- 在T187中Cdk2介导的酸化并不是唯一的p27降解的关键途径.
- 第二个独特的蛋白质溶解机制在G1阶段调节p27水平.
- 这些发现揭示了p27控制细胞增殖的更复杂的调节网络.
更多相关视频
12:02Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
08:33Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
Published on: December 5, 2017
相关概念视频
Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
